Assessing How Normal Variations in CT Scanning Affects Its Interpretation (NCT03038568)
Stability of Radiomic Features for Abdominal Tumors on Contrast Enhanced CT
🩺 Plain-English Summary (8th-Grade Level)
The purpose of the study is to see how measurements of tumor differences vary with slight changes in CT scan parameters. Reproducible radiomic features can be extracted for abdominal tumors, and specifically colorectal liver metastases, imaged with clinical CT scanners even in the setting of variable scan parameters and variable contrast timing. Participants will be consented to undergo an additional CT of their abdomen.
Who can join: Review the eligibility criteria below.
Location: Memorial Sloan Kettering Cancer Center — New York, New York
Age range: 18 Years
🧪 Interventions in This Study
- CT scan (DIAGNOSTIC_TEST)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (2 Sites)
- Memorial Sloan Kettering Cancer Center — New York, New York
- MD Anderson Cancer Center, Texas (Data collection only) — Houston, Texas
📞 Contact the Study Coordinator
Phone: (800) 525-2225
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Colorectal Cancer Metastatic
- A Phase 1b Study of WU-NK-101 in Combination With Cetuximab — San Francisco, California
- Isunakinra Alone and in Combination With Pembrolizumab in Patients With Colorectal Cancer (MSS) — Los Angeles, California
- BAL/BOT/agenT-797 in pMMR CRC With Liver Metastases — La Jolla, California
- Pilot Study of an Implantable Microdevice for In Situ Evaluation of Drug Response in Patients With Colorectal Liver Metastasis — Lake Success, New York
- Platform Study of Immunotherapy Combinations in Colorectal Cancer Liver Metastases — New York, New York
Explore by condition: All Colorectal Cancer Metastatic clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.